Strategies for Improving Linkage-to-Care After Eye Disease Screening

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT06943599
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
60 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Text Message Reminder — OTHER
    Participants referred to the eye hospital after screening will receive a text message reminding them to attend their referral visit.
  • Health Worker Visit — OTHER
    Participants referred to the eye hospital after screening will receive a home visit from a health worker reminding them to attend their referral visit.

Study Details

The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.

Key Dates

Start date
Feb 1, 2026
Status verified
Apr 2026
Primary completion
Jun 30, 2028
Completion
Jun 30, 2028

Study Design

Enrollment
3,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Text Message Reminders
  • Experimental: Health Worker
  • No Intervention: No Intervention

Primary Outcome Measure

Referral Visit Attendance [ Time Frame: 21 days after screening ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94158-

Find similar trials in San Francisco, CA

By condition
Diabetic retinopathyGlaucoma
By specialty
OphthalmologyRetina
By research site
University of California, San Francisco· San Francisco, CA

Related Studies